Join the club for FREE to access the whole archive and other member benefits.

UNITY Biotechnology

Biotechnology company devoted to research of restoring human health.

UNITY Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.

Visit website:

People at UNITY Biotechnology

Company Representative

Chief Medical Officer at Unity Biotechnology.

Company Representative

Chairman and CEO of UNITY Biotechnology.


Co-Founder and President, Unity Biotechnology

Company Representative

Co-Founder and President at Unity Biotechnology.

Company Representative

Chief Executive Officer at UNITY Biotechnology.

UNITY Biotechnology News

Unity Biotechnology launches clinical trial of a new senolytic - 13-Oct-2020

A new approach to treat diabetic macular oedema


Labiotech gathers feedback from European biotechs on Unity failure

Labiotech - 28-Aug-2020

General feeling that failures are bound to happen - but that their approaches can succeed


Reason examines the failure of Unity Biotechnology's phase 2 senolytics trial

Fight Aging! - 18-Aug-2020

Disappointing first result - but lessons learnt and plenty of other strategies available


Research into klotho is at a very interesting point

Fight Aging! - 03-Jun-2019

Research community is littered with interesting, promising foundations for therapies to treat aging


UNITY Biotechnology expands trial of osteoarthritis senolytic

UNITY Biotechnology - 22-Jan-2019

Initial results must be promising to enrol more patients at highest dosage


UNITY Biotechnologies Selects a New Senolytic Candidate

Life Extension Advocacy Foundation (LEAF) - 14-Jan-2019

Very early days but good to have more senolytics in the pipeline